YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)
Clinical trial NCT04000737 · COMPLETED
Trial details
- NCT number
- NCT04000737
- Sponsor
- Yiviva Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-10
- Primary completion
- 2024-03-22
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.